Research Directory

Market Commentary: How risky are European biotechs?

Read more

Cheap capital gives rise to integrated pharma R&D

Read more

Commentary: Thought disruption in R&D discovery

Read more

Market Analysis: The outlook for European pharma

Read more

New risk capital for European companies

Read more

A strategy for treating traumatic brain injury

Read more

Debate heats up over germline editing

Read more

Bioelectronics creates new horizon for medicine

Read more

Has à la carte genetic medicine arrived?

Read more

Britain looks to life outside the EU

Read more